《大行報告》野村下調瑞聲(02018.HK)評級至「中性」削目標價至47.8元
野村發表報告表示,將瑞聲科技(02018.HK)的投資評級,由原來的「買入」下調至「中性」,目標價由51元調低至47.8元,此相當2019年下半年至2020年上半年綜合市盈率17倍。
該行表示,對瑞聲科技2019財年至2020財年盈利預測分別下調9%及8%,因為看到中美貿易局勢緊張以及對華為的禁令,令內地智能手機客戶的增長動力較預期疲弱;而在淡季期間,該行對於公司旗下美國客戶的聲學及觸控元件的定價壓力或高於預期。
野村稱,繼續看好瑞聲在新業務及產品升級方面的努力,但考慮到目前宏觀環境具不確定性,公司或需要更長時間才能夠復甦。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.